NCT02317458View on ClinicalTrials.gov

Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-2) Trial - THE CHART-2 TRIAL

PHASE3UnknownINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

June 30, 2017

Primary Completion Date

March 31, 2020

Conditions

Heart Failure

Interventions

BIOLOGICAL

Experimental

One active arm with standard of car and treatment with C3BR-CQR-1 using intramyocardial injection

BIOLOGICAL

Sham comparator

One arm with standard of care undergoing a sham procedure

Sponsors

Lead Sponsor

Celyad Oncology SA

All Listed Sponsors

lead

Celyad Oncology SA

INDUSTRY

NCT02317458 - Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-2) Trial - THE CHART-2 TRIAL | Biotech Hunter | Biotech Hunter